• Twitter
  • Linkedin
  • Careers
  • News
  • Contact
Amplyx
  • Who We Are
  • Our Focus
  • Our Pipeline
  • Patient Community
  • Investors
  • Menu
2019, Press Release

Amplyx Announces Presentations on Fosmanogepix (APX001) at IDWeek 2019 and the 9th Congress on Trends in Medical Mycology (TIMM-9)

Read more
September 24, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-24 05:00:442020-08-18 13:49:45Amplyx Announces Presentations on Fosmanogepix (APX001) at IDWeek 2019 and the 9th Congress on Trends in Medical Mycology (TIMM-9)
2019, Press Release

Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients

Read more
September 16, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-16 11:08:172020-08-18 13:49:53Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients
2019, Press Release

Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia

Read more
September 16, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-16 11:06:362020-06-08 10:49:55Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
2019, Press Release

FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications

Read more
September 9, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-09 05:00:122020-05-19 10:37:20FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications
2019, Press Release

Amplyx Pharmaceuticals Announces Presentations at the 29th ECCMID in Amsterdam

Read more
April 12, 2019/by Lauren Fish
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 Lauren Fish https://amplyx.com/wp-content/uploads/2019/11/logo.svg Lauren Fish2019-04-12 05:48:132020-05-19 10:37:04Amplyx Pharmaceuticals Announces Presentations at the 29th ECCMID in Amsterdam
2019, Press Release

FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis

Read more
February 11, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-02-11 06:12:262020-05-19 10:36:43FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
2019, Press Release

Antimicrobials Working Group Announces Updates to Leadership Team

Read more
January 31, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-01-31 15:12:552020-02-26 10:50:19Antimicrobials Working Group Announces Updates to Leadership Team
2018, Press Release

Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection

Read more
November 12, 2018/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2018-11-12 16:35:132020-02-26 10:50:30Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection
2018, Press Release

Amplyx Announces Presentations on APX001 at American Society for Microbiology Microbe 2018 and the 20th Symposium on Infections in the Immunocompromised Host

Read more
June 7, 2018/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2018-06-07 05:00:222020-02-26 14:18:54Amplyx Announces Presentations on APX001 at American Society for Microbiology Microbe 2018 and the 20th Symposium on Infections in the Immunocompromised Host
2018, Press Release

Amplyx Pharmaceuticals to Participate in BIO International Convention Panel and Present at Jefferies Global Healthcare Conference

Read more
June 5, 2018/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2018-06-05 05:12:532020-02-26 14:20:44Amplyx Pharmaceuticals to Participate in BIO International Convention Panel and Present at Jefferies Global Healthcare Conference
Page 2 of 3123
Amplyx © Copyright 2021 Privacy Policy EU Privacy Policy
Scroll to top